A study has found that EPO (erythropoietin) – best known as a performance-enhancing drug in sport – may improve cognitive functioning in patients suffering from bipolar disorder or depression. This ...

The increasingly common practice of using a synthetic form of the hormone EPO to maintain normal red blood cell levels in chronic kidney disease patients may increase cardiovascular risks, according ...

Two things happen following a heart attack--necrosis (normal cell death) and apoptosis (programmed cell death) -- and both are bad. Now researchers in Japan have found that a single intravenous dose ...

A research team from Mannheim, Göttingen, Varna, and Princeton has discovered in animal studies with mice that the growth ...

Leuven, Belgium − Many patients with a chronic disease or cancer have to contend with anemia − and the severe fatigue that accompanies anemia impedes the patient considerably in his or her daily ...

John A. Moran Eye Center researchers continue to shed new light on the potential of the hormone erythropoietin (EPO) to treat eye disease. EPO increases red blood cell production, and is already used ...

Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a study published today in the New England Journal of Medicine. The findings ...

Since 1989, physicians have prescribed the hormone erythropoietin (EPO) to combat anemia from blood loss, kidney failure, and cancer treatments. This compound orchestrates red blood cell production.